Luminex’s two multiplexing technologies, xMAP® and xTAG® allow creative researchers and our commercial partners the ability to develop protein or genomic assays on a proven, open testing platform. Join a community of thousands of researchers and over 50 partners who efficiently monitor up to 500 relevant biomarkers in a single sample and accelerate their understanding of complex biological systems.
The world’s most widely used multiplexing technology for detection biomarkers.
Our proven technology for making nucleic acid assay development and optimization easier.
xMAP Technology is adaptable to many biological assays, including immunoassays, nucleic acid, enzyme activity, and more.
With xMAP Technology, you can buy ready-to-use, validated assays from our partners, or be creative and build your own custom assays to precisely fit your research needs.
Easily browse our entire collection of peer-reviewed research that utilizes and records results with Luminex’s technologies and applications.